I was wondering whether anyone could suggest sources of information about amplified genes in cancer, especially if the website tries to combine it with (over)expression information. We wrote a review on amplified and expressed genes recently and are trying to get a sense of what else is out there, so that when we update it we make sure we get different sources of information, not just a search of the literature.
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
It would be helpful if you listed the sources that you already have (for the benefit of other users who find this thread and to prevent duplication of resources you are already aware of).
That being said some resources that spring to mind are listed below. Mostly these are initiatives that have created or are in the process of creating data that would provide both amplification and expression data, via next generation whole genome shotgun (WGS) and RNA sequencing (RNA-seq) or copy-number + expression microarrays.
Oncomine [registration required]
The Cancer Genome Anatomy Project (CGAP)
The Cancer Genome Characterization Initiative (CGCI; may soon have relevant data)
The Cancer Genome Atlas (TCGA; relevant data gradually entering the public domain)
The international cancer genome consortium (ICGC)
The database of genomic variants
-
Here is a list of the ones we have got already- CONAN (http://www.sanger.ac.uk/cgi-bin/gene...nan/search.cgi)
- Cancer Genome Workbench (https://cgwb.nci.nih.gov/)
- Breast (http://www.itb.cnr.it/breastcancer/)
- Integrative Oncogenomics Cancer Browser - IntOGen (http://www.intogen.org/)
- Oncomine (http://www.oncomine.org/)
Oh, and of course there is our website too: http://amplicon.icr.ac.ukLast edited by danielsbrewer; 09-23-2010, 12:40 AM.
Comment
-
We've put together a resource which allows one to query for over-expression and amplification in Cancer genomics samples, particularly those profiled by The Cancer Genome Atlas.
Here are some related threads if you're interested:
Registered SEQanswers sponsors/vendors can post commercial content here. Please support our sponsors!
Registered SEQanswers sponsors/vendors can post commercial content here. Please support our sponsors!
Good luck!
------------------------------
GenePool is making genomics data management, analysis, and sharing easier!
Products @ www.stationxinc.comLast edited by GenePool; 11-23-2014, 09:26 PM.
Comment
Latest Articles
Collapse
-
by seqadmin
The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist...-
Channel: Articles
04-22-2024, 07:01 AM -
-
by seqadmin
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...-
Channel: Articles
04-04-2024, 04:25 PM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, Yesterday, 08:47 AM
|
0 responses
12 views
0 likes
|
Last Post
by seqadmin
Yesterday, 08:47 AM
|
||
Started by seqadmin, 04-11-2024, 12:08 PM
|
0 responses
60 views
0 likes
|
Last Post
by seqadmin
04-11-2024, 12:08 PM
|
||
Started by seqadmin, 04-10-2024, 10:19 PM
|
0 responses
60 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 10:19 PM
|
||
Started by seqadmin, 04-10-2024, 09:21 AM
|
0 responses
54 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 09:21 AM
|
Comment